Metabolic syndrome as a risk factor for neurological disorders. (Q34224030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Metabolic syndrome as a risk factor for neurological disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Vincenza Frisardi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Akhlaq A Farooqui

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Tahira Farooqui

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

15 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

741-762

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21997383%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and trends in obesity among US adults, 1999-2008

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Transcriptional control of apolipoprotein A-I gene expression in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

21 January 2018

Adipokines in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome: a clinical and molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Modern science versus the stigma of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Inflammatory lipid mediators in adipocyte function and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Adiposity, type 2 diabetes, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Obesity wars: molecular progress confronts an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Fuel sensing and the central nervous system (CNS): implications for the regulation of energy balance and the treatment for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Gastrointestinal hormones and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The brain and the metabolic syndrome: not a wireless connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Plasticity of central autonomic neural circuits in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

A brain-liver circuit regulates glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Brain glucose sensing: a subtle mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Hypothalamic sensing of fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Blood glucose levels modulate efferent activity in the vagal supply to the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Hypothalamic K(ATP) channels control hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The role of the insulin-like growth factors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The expanding TOR signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

A link between protein translation and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Insulin, leptin and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Leptin receptor signaling and the regulation of mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The action of leptin in the ventral tegmental area to decrease food intake is dependent on Jak-2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Dietary fat, insulin sensitivity and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Fish oil prevents insulin resistance induced by high-fat feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The emerging role of FOXO transcription factors in pancreatic beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Selective interaction between leptin and insulin signaling pathways in a hepatic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The state of lipid rafts: from model membranes to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The nutritional and clinical significance of lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Insulin in the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Distribution of insulin receptor-like immunoreactivity in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Oxidative stress is associated with adiposity and insulin resistance in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Protein kinase B (PKB/Akt)--a key regulator of glucose transport?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Prevention of insulin resistance by n-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Targeting ceramide synthesis to reverse insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Physiological actions of diacylglycerol outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Diacylglycerol oil for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The sphingolipid salvage pathway in ceramide metabolism and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Ceramides in insulin resistance and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Endocannabinoids and the regulation of their levels in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The endocannabinoid system in obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The endocannabinoid system and the control of glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Endocannabinoids and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The endocannabinoid system as a target for the treatment of motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Contribution of lipid dynamics on the inhibition of bovine brain synaptosomal Na+-K+-ATPase activity induced by 4-hydroxy-2-nonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Can the liver X receptor work its magic in skeletal muscle too?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

LIPID arrays: new tools in the understanding of membrane dynamics and lipid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Body mass index and magnetic resonance markers of brain integrity in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome: from epidemiology to systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome as a predictor of ischemic stroke in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Diagnosis, prevention, and intervention for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Hyperinsulinemia and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Links between Alzheimer's disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Impaired insulin signaling and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Type 2 diabetes and risk of cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Genes, stress, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

The stress system in the human brain in depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Altered balance of gamma-aminobutyric acidergic and glutamatergic afferent inputs in rostral ventrolateral medulla-projecting neurons in the paraventricular nucleus of the hypothalamus of renovascular hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

Oxysterol as a marker of atherogenic dyslipidemia in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0840-1

IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination

21 January 2018

1 reference

12 December 2020

Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data

1 reference

12 December 2020

What’s in a Name? In Search of Leptin’s Physiologic Role1

1 reference

12 December 2020

Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes

1 reference

12 December 2020

Clustering trend of components of metabolic syndrome

1 reference

12 December 2020

Glucagon-like peptide-1 and energy homeostasis

1 reference

12 December 2020

Dietary fat intake and risk of type 2 diabetes in women

1 reference

12 December 2020

Lipid mediators of insulin resistance

1 reference

12 December 2020

Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers

1 reference

12 December 2020

Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance

1 reference

12 December 2020

A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide

1 reference

12 December 2020

The psychoneuroimmunology of depression

1 reference

12 December 2020

Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus

1 reference

12 December 2020

A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice

1 reference

12 December 2020

Central adiposity and increased risk of coronary artery disease mortality in older women

1 reference

12 December 2020

Endocannabinoids and neuroprotection

1 reference

12 December 2020

Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications

1 reference

12 December 2020

Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network.

1 reference

12 December 2020

Obesity and the role of adipose tissue in inflammation and metabolism

1 reference

12 December 2020

PI3K integrates the action of insulin and leptin on hypothalamic neurons

1 reference

12 December 2020

Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats

1 reference

12 December 2020

Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community

1 reference

12 December 2020

The role of calcium in the regulation of apoptosis

1 reference

12 December 2020

Mechanism for obesity-induced increase in myocardial lipid peroxidation

1 reference

12 December 2020

DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells

1 reference

12 December 2020

Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome

1 reference

12 December 2020

Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.

1 reference

12 December 2020

Impaired Insulin-Induced Platelet Antiaggregating Effect in Obesity and In obese NIDDM Patients

1 reference

12 December 2020

Effect of fatty acids on insulin release: role of chain length and degree of unsaturation

1 reference

12 December 2020

Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling.

1 reference

12 December 2020

Endothelial dysfunction and stroke

1 reference

12 December 2020

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

12 December 2020

Leptin: fundamental aspects

1 reference

12 December 2020

Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism

1 reference

12 December 2020

The metabolic syndrome of omega3-depleted rats. III. Brain phospholipids.

1 reference

12 December 2020

Thrombin-antithrombin III complexes in type II diabetes mellitus

1 reference

12 December 2020

Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis

1 reference

12 December 2020

Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

1 reference

12 December 2020

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

12 December 2020

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia

1 reference

12 December 2020